{"id":485073,"date":"2021-04-30T07:04:19","date_gmt":"2021-04-30T11:04:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-annual-general-meeting\/"},"modified":"2021-04-30T07:04:19","modified_gmt":"2021-04-30T11:04:19","slug":"oncolytics-biotech-announces-annual-general-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-annual-general-meeting\/","title":{"rendered":"Oncolytics Biotech\u00ae Announces Annual General Meeting"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n Management will also provide its annual corporate update after the conclusion of the meeting<\/i>\n <\/p>\n

\n SAN DIEGO, Calif.<\/span> and CALGARY, AB<\/span>, April 30, 2021<\/span> \/PRNewswire\/ —\u00a0Oncolytics Biotech\u00ae<\/sup> Inc. (NASDAQ: ONCY) (TSX: ONC), (the “Company<\/b>“) today announced that its upcoming 2021 Annual General Meeting (the “Meeting<\/b>“) will be held virtually at 12:00 p.m. Eastern Daylight Time<\/span> (ET) on Friday, May 7, 2021<\/span>. In light of limits on larger gatherings and in the best interest of the health and safety of our employees and shareholders, the Meeting will be held as a virtual-only shareholder meeting. After the Meeting and at the conclusion of shareholder voting, the management team will provide a corporate update and Q&A for institutional investors and analysts, along with a discussion of our first quarter 2021 financial results.<\/p>\n

\n \"Oncolytics\n <\/div>\n

The Company strongly encourages all shareholders, whether or not they plan on virtually attending the Meeting, to vote by completing and submitting their proxies or voting instruction forms, as applicable, well in advance of the Meeting. The deadline for voting or receiving proxies in relation to the Meeting is 12:00 p.m. ET on Wednesday<\/span>, May 5, 2021. Information on how to vote your shares by proxy is available in the Company’s Management Information Circular dated March 23, 2021<\/span> in respect of the Meeting. The information circular is available on the investor relations section of the Company’s website at https:\/\/ir.oncolyticsbiotech.com\/reports<\/a> and can also be accessed under the Company’s profile on SEDAR at https:\/\/www.sedar.com\/<\/a> and EDGAR at https:\/\/www.sec.gov\/edgar.shtml<\/a>. <\/p>\n

\n Who can Attend and Vote at the Meeting
<\/b>Registered shareholders (who have not appointed a proxyholder) and duly appointed proxyholders (including non-registered shareholders who appoint themselves as proxyholders) will be able to virtually attend the Meeting, vote and ask questions, all in real-time, provided they are connected to the internet. Non-registered shareholders who have not properly appointed themselves as proxyholder will be able to attend the Meeting as guests, but will not be able to vote or ask questions at the Meeting. Non-registered shareholders who wish to vote and ask questions at the Meeting must appoint themselves as proxyholder and register with our transfer agent, AST Trust Company (Canada<\/span>) (“AST<\/b>“) as described in the “How to Appoint and Register a Proxyholder<\/i>” section below.<\/p>\n

\n How to Appoint and Register a Proxyholder
<\/b>Non-registered shareholders who wish to appoint themselves and all shareholders (registered and non-registered) who wish to appoint a third party (other than the management nominees identified in the form of proxy or voting information form) as proxyholder to attend the Meeting must carefully follow the instructions in the Circular and on their form of proxy or voting instruction form. After submitting their form of proxy or voting instruction form to appoint themselves or a third party as a proxyholder, shareholders MUST<\/u><\/b> also complete the additional step of registering their proxyholder with AST and obtaining a control number for the Meeting by calling AST at +1-866-751-6315 (within North America<\/span>) or +1-212-235-5754 (outside of North America<\/span>) no later than 12:00 p.m. ET<\/span> on May 5, 2021<\/span>. Failure to register the proxyholder with AST will result in the proxyholder only being able to join the Meeting as a guest, with no ability to vote or ask questions. <\/b><\/p>\n

Registered shareholders who wish to attend the Meeting themselves do no need to register a proxyholder and can use the control number provided on their proxy form.<\/p>\n

\n How to Attend and Vote at the Virtual Meeting <\/b>\n <\/p>\n

\n Step 1<\/b>\u00a0– Log in online to the webcast at https:\/\/web.lumiagm.com\/158281614<\/a>. We recommend that shareholders log in to the webcast as early as possible but not later than 15 minutes before the time of the virtual Meeting to confirm that the web browser they are using is compatible.<\/p>\n

\n Step 2 <\/b>– Follow these instructions:<\/p>\n

\n Registered shareholders: <\/b>\n <\/p>\n